Eight-year follow-up in pediatric living donor kidney recipients receiving alemtuzumab induction-Reference-Cited by-同舟云学术

Eight-year follow-up in pediatric living donor kidney recipients receiving alemtuzumab induction

Published:2017-06-10 Issue:5 Volume:21 Page:e12941
ISSN:1397-3142
Container-title:Pediatric Transplantation
language:en
Short-container-title:Pediatr Transplantation

Author:

Kaabak Michael M.¹^ORCID,Babenko Nadeen N.²,Shapiro Ron³,Maschan Alexey A.⁴,Zokoev Allan K.²,Schekaturov Stanislav V.²,Vyunkova Julia N.²,Dymova Olga V.⁵

Affiliation:

1. Organ Transplant Division; Boris Petrovsky Research Center of Surgery; Moscow Russia

2. Kidney Transplant Department; Boris Petrovsky Research Center of Surgery; Moscow Russia

3. Mount Sinai Hospital; Surgery; Recanati/Miller Transplantation Institute; Icahn School of Medicine at Mt. Sinai; New York NY USA

4. Dmitry Rogachev Federal Clinic of Pediatric Hematology; Oncology; and Immunology; Moscow Russia

5. Laboratory Department; Boris Petrovsky Research Center of Surgery; Moscow Russia

Funder

Health Resources and Services Administration

Publisher

Wiley

Subject

Transplantation,Pediatrics, Perinatology and Child Health

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/petr.12941/fullpdf

Reference23 articles.

1. Alemtuzumab monoclonal antibody therapy;Flynn;Curr Opin Oncol,2000

2. Differential CD52 expression by distinct myeloid dendritic cell subsets: implications for alemtuzumab activity at the level of antigen presentation in allogeneic graft-host interactions in transplantation;Ratzinger;Blood,2003

3. Results from a human renal allograft tolerance trial evaluating the humanized CD52-specific monoclonal antibody alemtuzumab (CAMPATH-1H);Kirk;Transplantation,2003

4. Remission induction in non-Hodgkin lymphoma with reshaped human monoclonal antibody CAMPATH-1H;Hale;Lancet,1998

5. Alemtuzumab (Campath-IH) induction therapy and dendritic cells: impact on peripheral dendritic cell repertoire in renal allograft recipients;Kirsch;Transpl Immunol,2006

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Alemtuzumab induction is associated with decreased hospitalization rates in pediatric kidney transplant: A UNOS data review for safety and outcomes with common induction regimens;Pediatric Transplantation;2024-05-20

2. Long‐term outcomes of two‐dose alemtuzumab induction in pediatric kidney transplantation;Pediatric Transplantation;2024-04-16

3. Outcomes based on induction regimens in pediatric kidney transplantation: a NAPRTCS and PHIS collaborative study;Pediatric Nephrology;2023-05-08

4. Steroid‐free maintenance immunosuppression using alemtuzumab in pediatric kidney transplantation: Long‐term longitudinal follow‐up;Pediatric Transplantation;2021-10-23

5. Early outcomes comparing induction with antithymocyte globulin vs alemtuzumab in two steroid‐avoidance protocols in pediatric renal transplantation;Pediatric Transplantation;2020-02-29